Last reviewed: June 26, 2026

Last updated: June 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections require precise administration to maximize therapeutic benefit and minimize discomfort. Understanding approved injection sites, rotation patterns, and proper technique ensures consistent drug delivery and reduces risk of lipohypertrophy—localized fat thickening that develops when patients repeatedly inject the same area. PlexusDx patients receive detailed training materials with their compounded semaglutide to support safe, effective home administration.

Approved Semaglutide Injection Sites and Anatomy

Semaglutide is administered subcutaneously—meaning the needle penetrates skin and fatty tissue but not muscle. The FDA-approved injection sites include the abdomen, upper arm, and thigh. These locations contain sufficient subcutaneous tissue to safely accommodate the medication and allow consistent absorption into the bloodstream. The abdomen offers the largest surface area for rotation, while the upper arm and thigh provide alternative sites for patients who prefer variety or experience localized reactions.

The abdomen is the most commonly used injection site because it provides predictable absorption rates and allows patients to self-administer easily while seated. Optimal abdominal injection points are at least two finger-widths away from the belly button and below the rib cage. The upper arm injection site works well for patients with a partner or caregiver who can assist, as self-injection in this location is more challenging. The thigh offers adequate subcutaneous tissue and remains accessible for independent administration.

Rotating Injection Sites to Prevent Lipohypertrophy

Lipohypertrophy develops when patients inject the same subcutaneous location repeatedly over weeks or months, causing localized fat tissue to expand. This complication reduces medication absorption variability and can lead to inconsistent blood glucose or weight loss responses. Rotating injection sites across approved areas—switching between abdomen, upper arm, and thigh each week—prevents tissue damage and maintains predictable drug delivery. PlexusDx recommends establishing a systematic rotation pattern before beginning treatment.

A practical rotation strategy involves selecting a new body area each week: abdomen Week 1, upper arm Week 2, thigh Week 3, then returning to abdomen Week 4. Within each chosen area, select a different injection point, moving at least two finger-widths away from the previous injection. Keeping a simple injection log or calendar helps patients track injection sites and avoid repeating the same location within eight weeks. This disciplined approach prevents complications and maintains stable medication absorption over long-term treatment.

Step-by-Step Injection Technique and Administration Safety

Before injecting, wash your hands thoroughly with soap and water and allow the injection site skin to air-dry completely. Remove the medication from the refrigerator 15–30 minutes before injection to bring it closer to room temperature—this reduces injection discomfort and improves absorption. Inspect the medication for particles, discoloration, or cloudiness; do not inject if the solution appears abnormal. Prepare the injection site by cleaning it with an alcohol swab using a circular motion outward, then allow the alcohol to air-dry for at least 30 seconds.

Pinch the skin at the injection site between your thumb and forefinger to create a lifted fold of tissue. Insert the needle at a 90-degree angle straight into the pinched skin, then slowly depress the plunger to inject the medication. Hold the needle in place for three seconds after the plunger reaches the bottom, then withdraw the needle at the same angle you inserted it. Apply gentle pressure with a clean gauze pad if slight bleeding occurs, and do not massage the injection site—massaging can alter absorption rates and increase discomfort. Place the used needle in a designated sharps container and never reuse needles.

Managing Injection Discomfort and Common Administration Challenges

Injection pain varies among patients and typically decreases with repeated administration as anxiety diminishes and technique improves. Using a room-temperature or slightly warmed medication reduces the sensation of the injection, as does allowing the alcohol swab to dry completely before inserting the needle. Taking slow, deep breaths during the injection calms the nervous system and can diminish perceived pain. Some patients find that applying a cold pack to the injection site for 30 seconds immediately before administration numbs the area and reduces discomfort—however, avoid excessive cooling, which can harden the skin and make needle insertion more difficult.

Patients who experience needle anxiety may benefit from distraction techniques such as looking away during injection, listening to music, or engaging in conversation with a caregiver. If needle phobia severely limits medication adherence, oral semaglutide offers an alternative delivery method, available from PlexusDx starting at $249/month. Mild bruising or redness at the injection site typically resolves within 24–48 hours and does not require treatment. However, persistent pain, swelling, or signs of infection should be reported to a healthcare provider immediately.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide into my buttocks or other areas?

No—semaglutide is approved only for subcutaneous injection into the abdomen, upper arm, and thigh. These anatomical sites contain adequate subcutaneous tissue for consistent drug absorption. Buttocks and other areas have not been studied and may produce unpredictable medication levels. Always inject only into FDA-approved sites to ensure safety and efficacy.

How often should I rotate my injection sites?

Rotate injection sites weekly to prevent lipohypertrophy. Select a different body area each week—abdomen one week, upper arm the next, thigh the third—then return to abdomen in week four. Within each chosen area, move at least two finger-widths away from your previous injection point. This rotation strategy maintains consistent medication absorption and prevents localized fat tissue damage over long-term treatment.

What is lipohypertrophy and why does it matter?

Lipohypertrophy is abnormal fat tissue expansion that develops when patients repeatedly inject the same subcutaneous location. This complication reduces medication absorption predictability and can diminish the therapeutic response to semaglutide. Rotating injection sites prevents lipohypertrophy and ensures stable drug delivery. If you notice a lump or thickened area at previous injection sites, notify your healthcare provider.

Does PlexusDx provide training for proper semaglutide injection?

Yes—PlexusDx provides detailed instructional materials with all compounded semaglutide prescriptions, including step-by-step injection guides and site rotation schedules. Patients also receive access to customer support to address technique questions. PlexusDx compounded semaglutide starts at $149/month and includes these educational resources to support safe, effective home administration across all 50 states.

How does genetic testing personalize my semaglutide response?

PlexusDx Precision Peptide Genetic Test analyzes variants in semaglutide response pathways, including GLP1R rs6923761 and GIPR rs1800437, which influence how your body responds to GLP-1 receptor activation. The test maps 14 pathways and 150+ genetic insights to predict individual treatment response. This $99 add-on (available after your first treatment month) helps optimize your medication selection and dosing strategy for maximum weight loss and metabolic benefit.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves